- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.05. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 30 April 2025 - correction | - | ASX | ||
| 07.05. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 30 April 2025 | - | ASX | ||
| 07.05. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 30 April 2025 | - | ASX | ||
| 07.04. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 March 2025 | - | ASX | ||
| 07.04. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 March 2025 | - | ASX | ||
| 17.03. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Half-Year Financial Report | 1 | ASX | ||
| 07.03. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 28 February 2025 | - | ASX | ||
| G MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln | |||||
| 07.03. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 28 February 2025 | - | ASX | ||
| 17.02. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Indicative dividends calendar for 2025 | 1 | ASX | ||
| 07.02. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 January 2025 | 2 | ASX | ||
| 07.02. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 January 2025 | 1 | ASX | ||
| 09.01. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend component details | 1 | ASX | ||
| 08.01. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 31 December 2024 | 1 | ASX | ||
| 05.01. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 31 December 2024 | - | ASX | ||
| 02.01. | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend Reinvestment Plan Prices | 1 | ASX | ||
| 31.12.24 | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Final Dividend/Distribution for period ending 31 Dec 2024 | 1 | ASX | ||
| 19.12.24 | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Dividend Timetable | 2 | ASX | ||
| 06.12.24 | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Issued Units Outstanding as at 30 November 2024 | 2 | ASX | ||
| 04.12.24 | G MEDICAL INNOVATIONS HOLDINGS LIMITED: Monthly Disclosure Information as at 30 November 2024 | - | ASX |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,470 | -1,63 % | Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now | ||
| HIMS & HERS HEALTH | 52,24 | -4,60 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| BICO GROUP | 3,188 | -7,00 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| GERATHERM MEDICAL | 3,290 | 0,00 % | Geratherm Medical verlängert Kurzarbeit in Geratal | Geratherm Medical verlängert die Kurzarbeit in der Fieberthermometerproduktion am Standort Geratal der Geratherm Medical Germany GmbH bis zum 31. Dezember 2025. Das Unternehmen verweist auf die anhaltend... ► Artikel lesen | |
| DEXCOM | 76,66 | -1,02 % | DexCom Promotes COO Jacob Leach To Additional Role Of President | WASHINGTON (dpa-AFX) - DexCom, Inc. (DXCM) announced Tuesday the promotion of Jacob Leach to president, in addition to his current role as chief operating officer, which he has held since 2022.With... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,040 | -11,01 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
| PLUS THERAPEUTICS | 0,505 | -5,52 % | Plus Therapeutics Inc.: Plus Therapeutics' REYOBIQ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) | Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ RNA sequencing data show early tumor apoptosis and activation of innate immune responses Updated ReSPECT data... ► Artikel lesen | |
| HEALWELL AI | 0,958 | -1,08 % | HEALWELL meldet Rekord-Umsatzwachstum von 208 % im 1. Quartal 2025, einschließlich Rekordwachstum von 224 % bei KI- und Data-Science-Umsätzen | - HEALWELL erzielte im 1. Quartal 2025 einen Quartalsumsatz aus fortgeführten Geschäftsbereichen in Höhe von 14,1 Millionen $, was einer Steigerung von 208 % gegenüber 4,6
Millionen... ► Artikel lesen | |
| INVITAE | - | - | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 3,030 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain | BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| EMEIS | 10,440 | -3,78 % | emeis: Sales and business to end-March 20251 | Further rise in occupancy rates in France and abroad Occupancy rates growth, particularly in nursing homes (France, Northern Europe, Central Europe) Organic sales growth of +6.2%2, Occupancy... ► Artikel lesen | |
| CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen |
G MEDICAL INNOVATIONS HOLDINGS LTD gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu G MEDICAL INNOVATIONS HOLDINGS LTD finden Sie auf Wallstreet Online.